Related Experiment Video
Updated: Jul 31, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
497
Long non-coding RNAs regulate treatment outcome in leukemia: What have we learnt recently?
Huiping Shi1, Liang Gao2, Weili Zhang3
1The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
Cancer Medicine
|May 6, 2023
Summary
Long non-coding RNAs (lncRNAs) are emerging as key regulators in leukemia treatment resistance. Understanding lncRNA roles can help overcome drug resistance and personalize leukemia therapy.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Leukemia is a diverse blood cancer with significant mortality.
- Current treatments like chemotherapy and immunotherapy face challenges due to therapeutic resistance.
- Mechanisms of resistance are not fully understood, hindering effective treatment strategies.
Purpose of the Study:
- To review recent findings on long non-coding RNAs (lncRNAs) in regulating therapeutic resistance in leukemia.
- To discuss the potential of lncRNAs as therapeutic targets and biomarkers for leukemia treatment.
Main Methods:
- Literature review of studies investigating lncRNAs and drug resistance in leukemia.
- Analysis of molecular mechanisms underlying lncRNA-mediated resistance.
- Synthesis of current knowledge on lncRNA roles in various leukemia types.
Main Results:
- Dysregulated lncRNAs are implicated in resistance to multiple leukemia therapies.
- Specific lncRNAs influence the efficacy of chemotherapy, targeted therapy, and immunotherapy.
- lncRNAs affect key cellular pathways involved in drug resistance, including signaling and apoptosis.
Conclusions:
- lncRNAs represent promising targets for overcoming therapeutic resistance in leukemia.
- lncRNA profiling may aid in predicting treatment response and guiding individualized therapy decisions.
- Further research into lncRNA functions is crucial for developing novel strategies to improve leukemia patient outcomes.
Keywords:
hematopoietic stem cell transplantationleukemialong non-coding RNAtargeted therapytherapeutic resistancetreatment outcomeMore Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
10.1K
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.6K
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
01:20Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
01:23Regulation of Expression at Multiple Steps
957
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
957
02:24Regulation of Expression Occurs at Multiple Steps
22.9K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.9K
01:29Translational Regulation
47
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
47
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K